Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease

被引:0
|
作者
Naoyuki Fujimori [1 ]
Takeji Umemura [1 ]
Takefumi Kimura [1 ]
Naoki Tanaka [2 ,3 ]
Ayumi Sugiura [1 ]
Tomoo Yamazaki [1 ]
Satoru Joshita [1 ]
Michiharu Komatsu [1 ]
Yoko Usami [4 ]
Kenji Sano [4 ]
Koji Igarashi [5 ]
Akihiro Matsumoto [1 ]
Eiji Tanaka [1 ]
机构
[1] Department of Internal Medicine,Division of Gastroenterology,Shinshu University School of Medicine
[2] Department of Metabolic Regulation,Shinshu University Graduate School of Medicine
[3] Research Center for Agricultural Food Industry,Shinshu University
[4] Department of Laboratory Medicine,Shinshu University Hospital
[5] Bioscience Division,TOSOH Corporation
关键词
Autotaxin; Non-alcoholic fatty liver disease; Fibrosis; Ballooning;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
AIM To examine the relationship between serum autotaxin(ATX) concentrations and clinicopathological findings in non-alcoholic fatty liver disease(NAFLD) patients.METHODS One hundred eighty-six NAFLD patients who had undergone liver biopsy between 2008 and 2017 were retrospectively enrolled.Serum samples were collected at the time of biopsy and ATX was measured by enzyme immunoassays.Sera obtained from 160 healthy,nonobese individuals were used as controls.Histological findings were graded according to an NAFLD scoring system and correlations with serum ATX were calculated by Spearman’s test.Diagnostic accuracy was evaluated using the area under the receiver operating characteristic curve(AUC).Cut-off values were identified by the Youden index,and the nearest clinically applicable value to the cutoff was considered the optimal threshold for clinical convenience.RESULTS Serum ATX levels were significantly higher in NAFLD patients than in controls(0.86 mg/L vs 0.76 mg/L,P < 0.001) and correlated significantly with ballooning score and fibrosis stage(r = 0.36,P < 0.001 and r = 0.45,P < 0.001,respectively).Such tendencies were stronger in female patients.There were no remarkable relationships between ATX and serum alanine aminotransferase,lipid profiles,or steatosis scores.The AUC values of ATX for predicting the presence of fibrosis(≥ F1),significant fibrosis(≥ F2),severe fibrosis(≥ F3),and cirrhosis(F4),were all more than 0.70 in respective analyses.CONCLUSION Serum ATX levels may at least partially reflect histological severity in NAFLD.
引用
收藏
页码:1239 / 1249
页数:11
相关论文
共 50 条
  • [31] Serum Obestatin Concentrations in Non-Alcoholic Fatty Liver Disease (NAFLD) With Fibrosis
    Estep, Michael
    Abawi, Massihulla
    Bolden, Shanna
    Stepanova, Maria
    Hossain, Noreen
    Goodman, Zachary
    Chandhoke, Vikas
    Baranova, Ancha
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2010, 138 (05) : S802 - S802
  • [32] Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)
    Fernandez-Rodriguez, Conrado M.
    Aller, Rocio
    Luisa Gutierrez-Garcia, Ma
    Ampuero, Javier
    Gomez-Camarero, Judith
    Martin-Mateos, Rosa M.
    Burgos-Santamaria, Diego
    Miguel Rosales, Jose
    Aspichueta, Patricia
    Buque, Xabier
    Latorre, Mercedes
    Andrade, Raul J.
    Hernandez-Guerra, Manuel
    Romero-Gomez, Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (04) : 264 - 269
  • [33] Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis
    Gisondi, P.
    Barba, E.
    Girolomoni, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (02) : 282 - 287
  • [34] Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Ramai, Daryl
    Facciorusso, Antonio
    Vigandt, Erika
    Schaf, Bryan
    Saadedeen, Waleed
    Chauhan, Aditya
    di Nunzio, Sara
    Shah, Aashni
    Giacomelli, Luca
    Sacco, Rodolfo
    CELLS, 2021, 10 (12)
  • [35] Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease
    Sundelin, Elias Immanuel Ordell
    Gormsen, Lars Christian
    Heeboll, Sara
    Vendelbo, Mikkel Holm
    Jakobsen, Steen
    Munk, Ole Lajord
    Feddersen, Soren
    Brosen, Kim
    Hamilton-Dutoit, Stephen Jacques
    Pedersen, Steen Bonlokke
    Gronbaek, Henning
    Jessen, Niels
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (08) : 1761 - 1770
  • [36] Association of serum homocysteine levels with ultrasonographic grades of fatty liver and with hepatic fibrosis, as measured by transient elastography, in non-alcoholic fatty liver disease: an Indian perspective
    Srivastava, Aditya
    Tripathi, B. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 98 - 98
  • [37] Serum adiponectin levels correlate strongly with non-alcoholic steatohepatitis (NASH) grade and fibrosis stage in non-alcoholic fatty liver disease (NAFLD)
    Savvidou, Savvoula
    Goulis, John
    Hytiroglou, Prodromos
    Orfanou-Koumerkeridou, Eleni
    Frantzoulis, Peggy
    Panderis, Athanasia
    Arvanitakis, Constantine
    HEPATOLOGY, 2006, 44 (04) : 644A - 644A
  • [38] Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease
    Lemoine, Maud
    Ratziu, Vlad
    Kim, Minji
    Maachi, Mustapha
    Wendum, Dominique
    Paye, Francois
    Bastard, Jean Philippe
    Poupon, Raoul
    Housset, Chantal
    Capeau, Jacqueline
    Serfaty, Lawrence
    LIVER INTERNATIONAL, 2009, 29 (09) : 1431 - 1438
  • [39] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [40] ORAL AND GUT MICROBIOME DIVERSITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND HEPATIC FIBROSIS
    Mehta, Rohini
    Paik, James
    Felix, Sean C.
    Allawi, Hussain
    Schneider, Ingrid
    Lam, Brian P.
    Huong Pham
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2019, 156 (06) : S1295 - S1296